Base de dados : MEDLINE
Pesquisa : K01.752.566.479.171.132.937 [Categoria DeCS]
Referências encontradas : 548 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 55 ir para página                         

  1 / 548 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28112530
[Au] Autor:Salari P; Abdollahi M
[Ad] Endereço:Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
[Ti] Título:Ethics in Pharmacy Curriculum for Undergraduate Pharmacy Students: A Needs Assessment Study.
[So] Source:Arch Iran Med;20(1):38-42, 2017 Jan.
[Is] ISSN:1735-3947
[Cp] País de publicação:Iran
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Recent advances in pharmacy practice have created serious ethical challenges for the pharmacists. Pursuing a new philosophy of practice is required to overcome these challenges and optimize the standard of care. In this regard, the current ethics guideline in the Pharmacy curriculum used in Tehran University of Medical Sciences, does not provide a fully comprehensive understanding of the issue. Therefore, the aim of the present study was to revise the current curriculum based on a needs assessment study. METHODS: In this study, a two-part questionnaire was presented to pharmacists to obtain their views on the importance of topics in their daily routine practice. Part one of the questionnaire consisted of demographic data and part two of 23 topics in pharmacy ethics. RESULTS: Out of a total of 200 questionnaires, 158 questionnaires were returned. We reached consensus on 24 topics, of which 8 topics gained a score of higher than 4 (the highest score was considered to be 5) and the rest obtained a score of 3 and higher. The highest score pertained to the pharmacists' relationship with patients, awareness of the rules and regulations, and medication error. CONCLUSION: Based on the results, a revised curriculum was designed for ethics in pharmacy. It seems that the designed curriculum is context-based and will develop appropriate educational material regarding pharmacists' requirements in daily practice. Consideration of interactive methods for teaching the curriculum is highly recommended.
[Mh] Termos MeSH primário: Currículo/tendências
Educação em Farmácia/normas
Ética Farmacêutica/educação
Determinação de Necessidades de Cuidados de Saúde
Farmacêuticos/ética
Estudantes de Farmácia
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
Irã (Geográfico)
Masculino
Meia-Idade
Inquéritos e Questionários
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1703
[Cu] Atualização por classe:170817
[Lr] Data última revisão:
170817
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170124
[St] Status:MEDLINE
[do] DOI:0172001/AIM.009


  2 / 548 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27659415
[Au] Autor:Guérin A; Bussières JF
[Ad] Endereço:Pharmacy Practice Research Unit, CHU Sainte-Justine, Montréal, Québec, Canada.
[Ti] Título:[A pilot study of the professional ethical thinking of Quebec hospital pharmacists and pharmacy students].
[Ti] Título:Étude pilote du niveau d'accord à des énoncés sur l'éthique pharmaceutique d'étudiants en pharmacie et pharmaciens hospitaliers québécois..
[So] Source:Ann Pharm Fr;75(1):67-76, 2017 Jan.
[Is] ISSN:0003-4509
[Cp] País de publicação:France
[La] Idioma:fre
[Ab] Resumo:OBJECTIVE: The main objective was to assess the position of Quebec pharmaceutical community about pharmaceutical ethics statements. The second objective was to compare the level of agreement of pharmacy students and hospitals pharmacists. METHOD: Survey conducted one day given in 2012 and 2013 for students in 2013 and from 29/08/2014 to 02/09/2014 for pharmacists. A questionnaire of eight themes and 43 statements was developed: training and education (5 questions), clinical research (7) advertising and marketing (5) evaluation (5) dispensing medication (4), pharmaceutical care (9) economic aspect (6) and code of ethics (2). A Likert scale with four choices was used to measure the level of agreement. The primary outcome was the difference between the level of agreement of pharmacy students and hospital pharmacists. The Chi test was used. RESULTS: A total of 347 students and 398 pharmacists responded to the survey. There was a statistically significant difference regarding the level of agreement with 28 statements on 43. The differences focused on eight themes of the questionnaire, or training and education (3/5 significantly different questions), clinical research (2/7), advertising and marketing (2/5), Evaluation (4/5) dispensing medication (4/4), pharmaceutical care (5/9), economic aspect (6/6) and ethics (2/2). CONCLUSION: This study shows that there is a difference between pharmacists and pharmacy students about pharmaceutical ethics statements.
[Mh] Termos MeSH primário: Atitude do Pessoal de Saúde
Ética Farmacêutica
Farmacêuticos/ética
Estudantes de Farmácia
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
Seres Humanos
Meia-Idade
Serviço de Farmácia Hospitalar
Projetos Piloto
Quebeque
Inquéritos e Questionários
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170803
[Lr] Data última revisão:
170803
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160924
[St] Status:MEDLINE


  3 / 548 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:26645761
[Au] Autor:Albert BB; Albert OJ; Hofman PL; Gunn AJ; Kenealy T; Cutfield WS
[Ad] Endereço:Paediatric Endocrinologist, Liggins Institute, University of Auckland, Auckland. b.albert@auckland.ac.nz.
[Ti] Título:Proposed changes to the Pharmacy Council of New Zealand Code of Ethics would undermine the trusted position of pharmacists in the delivery of science based health care.
[So] Source:N Z Med J;128(1423):86-8, 2015 Oct 16.
[Is] ISSN:1175-8716
[Cp] País de publicação:New Zealand
[La] Idioma:eng
[Mh] Termos MeSH primário: Terapias Complementares
Ética Farmacêutica
Medicina Baseada em Evidências
[Mh] Termos MeSH secundário: Códigos de Ética
Seres Humanos
Nova Zelândia
Farmacêuticos/normas
[Pt] Tipo de publicação:LETTER
[Em] Mês de entrada:1603
[Cu] Atualização por classe:151209
[Lr] Data última revisão:
151209
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:151210
[St] Status:MEDLINE


  4 / 548 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26635239
[Au] Autor:McCarthy M
[Ad] Endereço:Seattle.
[Ti] Título:Hepatitis C drug maker puts profit ahead of patients, US Senate report charges.
[So] Source:BMJ;351:h6573, 2015 Dec 03.
[Is] ISSN:1756-1833
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Comitês Consultivos
Conflito de Interesses/economia
Custos de Medicamentos/ética
Indústria Farmacêutica/economia
Indústria Farmacêutica/ética
Governo Federal
Honorários Farmacêuticos/ética
Honorários Farmacêuticos/estatística & dados numéricos
Hepatite C Crônica/tratamento farmacológico
Hepatite C Crônica/economia
Relatório de Pesquisa
Sofosbuvir/economia
Sofosbuvir/uso terapêutico
[Mh] Termos MeSH secundário: Benzimidazóis/economia
Benzimidazóis/uso terapêutico
Ética Farmacêutica
Fluorenos/economia
Fluorenos/uso terapêutico
Seres Humanos
Estados Unidos
Uridina Monofosfato/análogos & derivados
Uridina Monofosfato/economia
Uridina Monofosfato/uso terapêutico
[Pt] Tipo de publicação:NEWS
[Nm] Nome de substância:
0 (Benzimidazoles); 0 (Fluorenes); 0 (ledipasvir, sofosbuvir drug combination); E2OU15WN0N (Uridine Monophosphate); WJ6CA3ZU8B (Sofosbuvir)
[Em] Mês de entrada:1603
[Cu] Atualização por classe:151204
[Lr] Data última revisão:
151204
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:151205
[St] Status:MEDLINE
[do] DOI:10.1136/bmj.h6573


  5 / 548 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26210257
[Au] Autor:Bolt I; van den Hoven M; Blom L; Bouvy M
[Ad] Endereço:Faculty of Humanities, Department of Philosophy and Religious Studies, Ethics Institute, Utrecht University, Utrecht, The Netherlands. l.l.e.bolt@uu.nl.
[Ti] Título:To dispense or not to dispense? Ethical case decision-making in pharmacy practice.
[So] Source:Int J Clin Pharm;37(6):978-81, 2015 Dec.
[Is] ISSN:2210-7711
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Ab] Resumo:In daily practice, pharmacists are regularly confronted with moral problems in which deciding what to do is not always a straightforward decision. In this contribution we show how the use of a specific method for moral deliberation can (in retrospect or prospective) aid moral judgements. We use the case of dispensing isotretinoin to demonstrate one ethical reflection method, namely the Utrecht Method.
[Mh] Termos MeSH primário: Tomada de Decisão Clínica/ética
Prescrições de Medicamentos
Ética Farmacêutica
[Mh] Termos MeSH secundário: Acne Vulgar/tratamento farmacológico
Interações Medicamentosas
Feminino
Seres Humanos
Isotretinoína/efeitos adversos
Isotretinoína/uso terapêutico
Princípios Morais
Farmacêuticos
Adulto Jovem
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
EH28UP18IF (Isotretinoin)
[Em] Mês de entrada:1607
[Cu] Atualização por classe:171031
[Lr] Data última revisão:
171031
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150727
[St] Status:MEDLINE
[do] DOI:10.1007/s11096-015-0170-8


  6 / 548 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26116189
[Au] Autor:Parcher JF; Khan IA
[Ad] Endereço:National Center for Natural Products Research, University of Mississippi, USA. Electronic address: chjfp@olemiss.edu.
[Ti] Título:Establishment of a 'natural' origin for phytochemicals.
[So] Source:J Chromatogr A;1406:347, 2015 Aug 07.
[Is] ISSN:1873-3778
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Mh] Termos MeSH primário: Produtos Biológicos/normas
Compostos Fitoquímicos/análise
Editoração/normas
[Mh] Termos MeSH secundário: Técnicas de Química Analítica/normas
Técnicas de Química Analítica/tendências
Suplementos Nutricionais/análise
Suplementos Nutricionais/normas
Ética Farmacêutica
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Biological Products); 0 (Phytochemicals)
[Em] Mês de entrada:1510
[Cu] Atualização por classe:170624
[Lr] Data última revisão:
170624
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150628
[St] Status:MEDLINE


  7 / 548 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:25838014
[Au] Autor:Poirier TI; Hecht KA; Lynch JC; Otsuka AS; Shafer KJ; Wilhelm MJ
[Ad] Endereço:Dr. Poirier is Professor and Senior Scholar, Southern Illinois University Edwardsville School of Pharmacy; Dr. Hecht is Associate Professor, Southern Illinois University Edwardsville School of Pharmacy; Dr. Lynch is Professor and Director of Clinical Programs, Southern Illinois University Edwardsvil
[Ti] Título:Health professions ethics rubric: validation of reliability in an interprofessional health ethics course.
[So] Source:J Dent Educ;79(4):424-31, 2015 Apr.
[Is] ISSN:1930-7837
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The aim of this study was to validate a health professions ethics rubric by an interprofessional team. The rubric was used by two pharmacy and two dental faculty members to score ethics cases submitted by 16 teams comprised of 80 pharmacy and 50 dental students. A debriefing session for each case was moderated by a non-rater faculty member to arrive at a consensus score for the cases. Interrater reliability was calculated for the four raters and the debriefing scores as well as the four raters without the debriefing scores. The overall interrater correlations were in the range of 0.790 to 0.906 for the four raters. Issues ranged from 0.320 to 0.758. Principles ranged from 0.610 to 0.838. Options ranged from 0.655 to 0.843. Analysis ranged from 0.667 to 0.918. Solution ranged from 0.739 to 0.886. With the inclusion of the consensus scores, the interrater correlations were even higher. The best correlations were for the overall score and solution components of the rubric. With further edits in the rubric and enhanced training by faculty raters and changes in the ethics learning session, the revised rubric could be evaluated again for grading. Further training for faculty using the rubric for grading student cases should enhance its reliability. Demonstrating to students the ethical decision making process using the rubric should enhance the validation process.
[Mh] Termos MeSH primário: Educação em Odontologia
Educação em Farmácia
Ética Odontológica/educação
Ética Farmacêutica/educação
Ensino/métodos
[Mh] Termos MeSH secundário: Beneficência
Confidencialidade/ética
Empatia/ética
Docentes
Docentes de Odontologia
Seres Humanos
Consentimento Livre e Esclarecido/ética
Equipe de Assistência ao Paciente
Autonomia Pessoal
Estudantes de Odontologia
Estudantes de Farmácia
Revelação da Verdade/ética
[Pt] Tipo de publicação:JOURNAL ARTICLE; VALIDATION STUDIES
[Em] Mês de entrada:1506
[Cu] Atualização por classe:150403
[Lr] Data última revisão:
150403
[Sb] Subgrupo de revista:D; IM
[Da] Data de entrada para processamento:150404
[St] Status:MEDLINE


  8 / 548 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:25636923
[Au] Autor:Leibovici L; Paul M
[Ad] Endereço:Medicine E, Rabin Medical Centre, Beilinson Hospital and Sackler Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Israel. Electronic address: leibovici@post.tau.ac.il.
[Ti] Título:Ethical dilemmas in antibiotic treatment: focus on the elderly.
[So] Source:Clin Microbiol Infect;21(1):27-9, 2015 Jan.
[Is] ISSN:1469-0691
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Maximal antibiotic treatment for all patients suspected of harbouring a bacterial infection is non-viable, because it will rapidly induce resistance and exhaust this finite resource. This raises two ethical dilemmas: the question of whether we are justified in increasing the danger to a present, named, patient so as to benefit future, unknown, patients; and whether we are allowed to do so without asking the present patient for consent. Although the considerations for healthy elderly patients are similar to younger adults, the answers are complex when addressing patients with dementia, severely reduced quality of life and at end of life. We argue that a public debate on the balance between benefit to a present patient versus harm to future patients should be conducted. Such a debate should include examinations of scenarios in which antibiotic treatment does not gain any benefit in a patient with infection: at the end of life; in situations in which resistance is such that empirical antibiotic treatment seldom matches the susceptibilities of the pathogen; and in patients with no quality of life. An explicit cost-benefit model, incorporating quality of life and risk of resistance, in computerized decision support might obviate a clinician's need to deal with these difficult issues at bedside.
[Mh] Termos MeSH primário: Antibacterianos/uso terapêutico
Infecções Bacterianas/tratamento farmacológico
Ética Farmacêutica
Serviços de Saúde para Idosos/ética
Qualidade de Vida
[Mh] Termos MeSH secundário: Idoso
Análise Custo-Benefício
Técnicas de Apoio para a Decisão
Seres Humanos
Prescrição Inadequada/prevenção & controle
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anti-Bacterial Agents)
[Em] Mês de entrada:1510
[Cu] Atualização por classe:150131
[Lr] Data última revisão:
150131
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150201
[St] Status:MEDLINE


  9 / 548 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:25248673
[Au] Autor:Lee RY; Moles R; Chaar B
[Ad] Endereço:The University of Sydney, Faculty of Pharmacy.
[Ti] Título:Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
[So] Source:Contraception;91(1):25-30, 2015 Jan.
[Is] ISSN:1879-0518
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: The recent legalization of mifepristone has given women in Australia a new option for termination of pregnancy. Pharmacists are well positioned to provide information and supply mifepristone for patients. However, there are ethical and legal concerns in Australia regarding the supply of mifepristone, as pharmacists may choose to conscientiously object to supplying mifepristone and are subject to differing abortion laws between states and territories in Australia. The objective of this study was to explore attitudes and knowledge of Australian pharmacists about mifepristone. STUDY DESIGN: Semistructured interviews were conducted with 41 registered pharmacists working in a pharmacy or hospital in Sydney, Australia. When data saturation was achieved, audiotaped transcripts were deidentified and transcribed verbatim. Data were thematically analyzed using a framework approach for applied policy research and categorized into the following themes: contextual, diagnostic, evaluative and strategic. RESULTS: Analysis of the transcripts yielded four themes: (a) pharmacists' contextual view on pregnancy termination, the role of the pharmacist and impact on the pharmacy workplace; (b) diagnostic reasons for differing views; (c) evaluation of actual and perceived pharmacy practice in relation to the supply of mifepristone and (d) strategies to improve pharmacists' services, awareness and education. CONCLUSION: Australian pharmacists in this study perceived themselves to have a potentially important role as medicine experts in patient health care and safety in medical termination of pregnancy. However, there was a general lack of clinical, ethical and legal knowledge about medical termination of pregnancy and its legislation. IMPLICATIONS: To ensure patient safety, well-being and autonomy, there is an imperative need for pharmacist-specific training and guidelines to be made available and open discussion to be initiated within the profession to raise awareness, in particular regarding professional accountability for full patient care.
[Mh] Termos MeSH primário: Abortivos Esteroides/efeitos adversos
Aborto Induzido/efeitos adversos
Atitude do Pessoal de Saúde
Mifepristona/efeitos adversos
Medicamentos sem Prescrição/efeitos adversos
Farmacêuticos
Serviços Urbanos de Saúde/recursos humanos
[Mh] Termos MeSH secundário: Abortivos Esteroides/economia
Aborto Induzido/economia
Aborto Induzido/ética
Aborto Induzido/legislação & jurisprudência
Serviços Comunitários de Farmácia/recursos humanos
Ética Farmacêutica
Feminino
Pesquisas sobre Serviços de Saúde
Seres Humanos
Legislação de Medicamentos/ética
Mifepristona/economia
New South Wales
Medicamentos sem Prescrição/economia
Educação de Pacientes como Assunto
Serviço de Farmácia Hospitalar/recursos humanos
Gravidez
Competência Profissional
Papel Profissional
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Abortifacient Agents, Steroidal); 0 (Nonprescription Drugs); 320T6RNW1F (Mifepristone)
[Em] Mês de entrada:1507
[Cu] Atualização por classe:141216
[Lr] Data última revisão:
141216
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:140925
[St] Status:MEDLINE


  10 / 548 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:24768272
[Au] Autor:Simpson B; Khatri R; Ravindran D; Udalagama T
[Ad] Endereço:Department of Anthropology, Durham University, Dawson Building, Lower Mountjoy, Stockton Rd., Durham DH1 3LE, UK. Electronic address: robert.simpson@durham.ac.uk.
[Ti] Título:Pharmaceuticalisation and ethical review in South Asia: issues of scope and authority for practitioners and policy makers.
[So] Source:Soc Sci Med;131:247-54, 2015 Apr.
[Is] ISSN:1873-5347
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Ethical review by expert committee continues to be the first line of defence when it comes to protecting human subjects recruited into clinical trials. Drawing on a large scale study of biomedical experimentation across South Asia, and specifically on interviews with 24 ethical review committee [ERC] members across India, Sri Lanka and Nepal, this article identifies some of the tensions that emerge for ERC members as the capacity to conduct credible ethical review of clinical trials is developed across the region. The article draws attention to fundamental issues of scope and authority in the operation of ethical review. On the one hand, ERC members experience a powerful pull towards harmonisation and a strong alignment with international standards deemed necessary for the global pharmaceutical assemblage to consolidate and extend. On the other hand, they must deal with what is in effect the double jeopardy of ethical review in developing world contexts. ERC members must undertake review but are frequently made aware of their responsibility to protect interests that go beyond the 'human subject' and into the realms of development and national interest [for example, in relation to literacy and informed consent]. These dilemmas are indicative of broader questions about where ethical review sits in institutional terms and how it might develop to best ensure improved human subject protection given growth of industry-led research.
[Mh] Termos MeSH primário: Ensaios Clínicos como Assunto/ética
Países em Desenvolvimento
Comitês de Ética em Pesquisa
Ética Farmacêutica
Ética em Pesquisa
Formulação de Políticas
Padrões de Prática Médica/ética
Uso Excessivo de Medicamentos Prescritos/ética
[Mh] Termos MeSH secundário: Fortalecimento Institucional/ética
Conflito de Interesses
Experimentação Humana/ética
Seres Humanos
Índia
Internacionalidade
Nepal
Sri Lanka
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Mês de entrada:1512
[Cu] Atualização por classe:150327
[Lr] Data última revisão:
150327
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:140429
[St] Status:MEDLINE



página 1 de 55 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde